Guangdong Institute of Innovative Drug Translational Medicine

The Guangdong Institute of Innovative Drug Translational Medicine (GIDTM) is a high-level research and development organization located in Guangzhou, China, focused on the translation of basic life science research into clinical therapeutics. Led by Academician Ding Jian, the institute specializes in oncology, metabolic diseases, and neuropsychiatric disorders, utilizing a platform-based approach to drug discovery. GIDTM integrates medicinal chemistry, structural biology, and pharmacology to develop small molecule inhibitors and targeted therapies. The organization functions as a bridge between academic discovery and industrial commercialization, maintaining multiple programs in the pre-clinical and early clinical stages. By fostering collaborations between academia, hospitals, and the pharmaceutical industry, GIDTM serves as a critical hub for biotech innovation in the Guangdong-Hong Kong-Macao Greater Bay Area.